🇺🇸 RB in United States
35 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 35
Most-reported reactions
- Drug Abuse — 5 reports (14.29%)
- Intentional Overdose — 5 reports (14.29%)
- Dizziness — 4 reports (11.43%)
- Feeling Abnormal — 4 reports (11.43%)
- Confusional State — 3 reports (8.57%)
- Drug Ineffective — 3 reports (8.57%)
- Hallucination — 3 reports (8.57%)
- No Adverse Event — 3 reports (8.57%)
- Peritoneal Dialysis Complication — 3 reports (8.57%)
- Abasia — 2 reports (5.71%)
Other Cardiovascular approved in United States
Frequently asked questions
Is RB approved in United States?
RB does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for RB in United States?
Kim, Seok Jin is the originator. The local marketing authorisation holder may differ — check the official source linked above.